Effects of testosterone buciclate on testicular and epididymal sperm functions in bonnet monkeys (Macaca radiata)

Effects of testosterone buciclate on testicular and epididymal sperm functions in bonnet monkeys... The effects of testosterone buciclate (TB), a long-acting androgen ester given i.m. at four sites (20 mg/site) on days 1 and 91 of the study period (360 days), on reproductive and hormonal parameters were evaluated in five adult male bonnet monkeys; untreated animals (n = 5) acted as controls to monitor seasonal changes in these parameters. In control animals, testicular volume remained unchanged throughout the study; sperm count, motility and gel penetrability decreased while the percentage of spermatozoa showing retention of cytoplasmic droplet and coiled tail increased in June–July (days 210–240), preceded by reduction in serum testosterone (T) levels on days 120–150 (March–April). The TB-treated animals showed reduced testicular volume (days 90–270), suppressed sperm motility and gel penetrability (days 45–240 except on day 120), decreased sperm count (days 75–270), and an increased percentage of spermatozoa showing retention of cytoplasmic droplet and coiled tail (days 45–240 except on day 120). Even though serum T levels remained elevated until day 300, these levels were within the physiological range. The changes induced by TB were reversible. The suppression of testicular and epididymal functions by TB indicates that this long-acting androgen may have the potentiality to induce and maintain reversible sterility, but further evaluation needs to be carried out to develop an appropriate dosage regimen that would prevent return to normal functions in order to develop this long-acting androgen as a hormonal male contraceptive. The suppressive effects of TB on testicular and sperm functions, while maintaining physiological androgen levels, would be an advantage in the use of this drug in combination with hormonal antispermatogenic agents. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Contraception Elsevier

Effects of testosterone buciclate on testicular and epididymal sperm functions in bonnet monkeys (Macaca radiata)

Loading next page...
 
/lp/elsevier/effects-of-testosterone-buciclate-on-testicular-and-epididymal-sperm-n3XuNV3Pfx
Publisher site
See Article on Publisher Site

Abstract

The effects of testosterone buciclate (TB), a long-acting androgen ester given i.m. at four sites (20 mg/site) on days 1 and 91 of the study period (360 days), on reproductive and hormonal parameters were evaluated in five adult male bonnet monkeys; untreated animals (n = 5) acted as controls to monitor seasonal changes in these parameters. In control animals, testicular volume remained unchanged throughout the study; sperm count, motility and gel penetrability decreased while the percentage of spermatozoa showing retention of cytoplasmic droplet and coiled tail increased in June–July (days 210–240), preceded by reduction in serum testosterone (T) levels on days 120–150 (March–April). The TB-treated animals showed reduced testicular volume (days 90–270), suppressed sperm motility and gel penetrability (days 45–240 except on day 120), decreased sperm count (days 75–270), and an increased percentage of spermatozoa showing retention of cytoplasmic droplet and coiled tail (days 45–240 except on day 120). Even though serum T levels remained elevated until day 300, these levels were within the physiological range. The changes induced by TB were reversible. The suppression of testicular and epididymal functions by TB indicates that this long-acting androgen may have the potentiality to induce and maintain reversible sterility, but further evaluation needs to be carried out to develop an appropriate dosage regimen that would prevent return to normal functions in order to develop this long-acting androgen as a hormonal male contraceptive. The suppressive effects of TB on testicular and sperm functions, while maintaining physiological androgen levels, would be an advantage in the use of this drug in combination with hormonal antispermatogenic agents.

Journal

ContraceptionElsevier

Published: Aug 1, 1995

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off